Moderna (MRNA) call put ratio 2.6 calls to 1 put into quarter results and outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St set for tepid open as oil prices fall, Treasury yields rise
- Oil prices edge lower on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Moderna (MRNA) Shares Rally After Topping Q2 Estimates
August 3, 2022 9:58 AM EDTModerna (NASDAQ: MRNA) shares jumped more than 13% in early Wednesday trading after it posted earnings before the open Wednesday, topping analyst earnings and revenue consensus estimates.
The pharmaceutical company revealed second-quarter earnings of $5.24 per share, $0.70 better than the analyst estimate of $4.54. Revenue for the quarter came in at $4.7 billion versus the consensus estimate of $4.07 billion.
Moderna's said... More
